Growing community of inventors

Scottsdale, AZ, United States of America

Sandra J Gendler

Average Co-Inventor Count = 5.77

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 1

Sandra J GendlerPeter A Cohen (5 patents)Sandra J GendlerMary L Disis (3 patents)Sandra J GendlerDustin B McCurry (3 patents)Sandra J GendlerLatha B Pathangey (3 patents)Sandra J GendlerShannon E Smith (2 patents)Sandra J GendlerJoseph Lustgarten (2 patents)Sandra J GendlerJessica E Gorman (2 patents)Sandra J GendlerDominique B Hoelzinger (2 patents)Sandra J GendlerAna L Dominguez (2 patents)Sandra J GendlerSandra J Gendler (5 patents)Peter A CohenPeter A Cohen (5 patents)Mary L DisisMary L Disis (27 patents)Dustin B McCurryDustin B McCurry (3 patents)Latha B PathangeyLatha B Pathangey (3 patents)Shannon E SmithShannon E Smith (2 patents)Joseph LustgartenJoseph Lustgarten (2 patents)Jessica E GormanJessica E Gorman (2 patents)Dominique B HoelzingerDominique B Hoelzinger (2 patents)Ana L DominguezAna L Dominguez (2 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Mayo Foundation for Medical Education and Research (5 from 1,756 patents)

2. University of Washington (3 from 2,117 patents)


5 patents:

1. 11739296 - Methods and materials for expanding antigen-specific T cells in culture

2. 11464839 - Methods and vaccines for inducing immune responses to multiple different MHC molecules

3. 10647961 - Methods and materials for expanding antigen-specific T cells in culture

4. 10166292 - Blocking IL-9 signaling in conjunction with chemotherapy to treat cancer

5. 9833512 - Blocking IL-9 signaling in conjunction with chemotherapy to treat cancer

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/22/2026
Loading…